Bavarian Nordic A/s (OTC: BVNR.Y)
Bavarian Nordic A/s Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
Bavarian Nordic A/s Company Info
Bavarian Nordic A/S focuses on the development, manufacturing and commercialization of cancer immunotherapies and vaccines for infectious diseases. It specializes in cancer immunotherapy which includes cancer pipeline, which focuses on therapeutic vaccines for breast, lung, ovarian and prostate cancer. Its products include IMVAMUNE for Ebola, HPV, HBV, and HIV diseases. The company was founded in 1994 and is headquartered in Kvistgaard, Denmark.
News & Analysis
What Monkeypox Could Mean for These 2 Stocks?
Vaccine companies saw stock prices spike during the COVID pandemic. The same could happen amid a new outbreak.
Are These 4 Stocks Smart Buys With the Monkeypox Outbreak?
The monkeypox opportunity could already be baked into the prices of these stocks.
Valuation
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.